Connect with us
  • Elysium


Welcoming a new age of precision neuroscience



NR Times reports on how the pioneering work of Aprinoia Therapeutics could influence better patient outcomes in neuro-rehab; in conversation with chief medical officer Bradford Navia.

‘Precision neuroscience’ is a term which encapsulates the ceaseless drive for more targeted and effective brain treatments and diagnoses.

Not to be confused with Elon Musk’s neuro-tech startup of the same name, it sits at the intersect between two emergent health innovation trends; the rise of precision medicine – tailored interventions that consider genes, environments and lifestyles – and an acceleration of our understanding of the neurological world.

On the frontline of the precision neuroscience movement is Aprinoia, a clinical-stage biotech headquartered in Boston which is opening up new possibilities for the diagnosis and treatment of neuro conditions including Alzheimer’s and Parkinson’s.

Read this and more exclusive content every day as an NR Times online subscriber. Just £2.99 a month, cancel anytime.

Login Join Now